That's where I want to see how this plays out. The 54.20 offer isn't official yet. He is only talking at this point. Even though the board "accepted", it doesnt matter that much, it only means they wont do a poison pill. It is still up to the shareholders, which the board holds very little percentage wise.
Once the offer material, terms, and financing conditions are announced, it becomes real. I hope he accounts for a CVR (contingent value right) + hard cash = 54.20. If you're buying something, you don't want to walk in to a complete sham, where 50+% of the accounts are bots. That's just misrepresentation.
This is a common practice in other tech/pharma companies where a buyout occurs via SPAC or otherwise and certain agreed upon thresholds need to be met for the buyer to pay out fully, like sales goals or FDA approvals.
That's where I want to see how this plays out. The 54.20 offer isn't official yet. He is only talking at this point. Even though the board "accepted", it doesnt matter that much, it only means they wont do a poison pill. It is still up to the shareholders, which the board holds very little percentage wise.
Once the offer material, terms, and financing conditions are announced, it becomes real. I hope he accounts for a CVR (contingent value right) + hard cash = 54.20. If you're buying something, you don't want to walk in to a complete sham, where 50+% of the accounts are bots. That's just misrepresentation.
This is a common practice in other tech/pharma companies where a buyout occurs via SPAC or otherwise and certain agreed upon thresholds need to be met for the buyer to pay out fully, like sales goals or FDA approvals.